- Home
- NYT vs BRKR Comparison
NYT vs BRKR Comparison
Compare NYT & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYT
- BRKR
- Stock Information
- Founded
- NYT 1851
- BRKR 1960
- Country
- NYT United States
- BRKR United States
- Employees
- NYT N/A
- BRKR N/A
- Industry
- NYT Newspapers/Magazines
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- NYT Consumer Discretionary
- BRKR Industrials
- Exchange
- NYT Nasdaq
- BRKR Nasdaq
- Market Cap
- NYT 9.3B
- BRKR 5.3B
- IPO Year
- NYT N/A
- BRKR 2000
- Fundamental
- Price
- NYT $58.49
- BRKR $32.11
- Analyst Decision
- NYT Buy
- BRKR Buy
- Analyst Count
- NYT 6
- BRKR 11
- Target Price
- NYT $60.33
- BRKR $50.00
- AVG Volume (30 Days)
- NYT 1.4M
- BRKR 4.6M
- Earning Date
- NYT 11-03-2025
- BRKR 11-04-2025
- Dividend Yield
- NYT 1.23%
- BRKR 0.62%
- EPS Growth
- NYT 19.25
- BRKR N/A
- EPS
- NYT 1.93
- BRKR 0.52
- Revenue
- NYT $2,661,490,000.00
- BRKR $3,442,800,000.00
- Revenue This Year
- NYT $9.93
- BRKR $4.44
- Revenue Next Year
- NYT $6.51
- BRKR $1.71
- P/E Ratio
- NYT $30.31
- BRKR $62.02
- Revenue Growth
- NYT 7.88
- BRKR 10.36
- 52 Week Low
- NYT $44.83
- BRKR $28.53
- 52 Week High
- NYT $62.24
- BRKR $72.94
- Technical
- Relative Strength Index (RSI)
- NYT 50.64
- BRKR 46.69
- Support Level
- NYT $57.16
- BRKR $30.31
- Resistance Level
- NYT $59.52
- BRKR $32.56
- Average True Range (ATR)
- NYT 0.96
- BRKR 1.45
- MACD
- NYT -0.23
- BRKR 0.30
- Stochastic Oscillator
- NYT 46.74
- BRKR 60.58
About NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.